BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13884680)

  • 1. [Present status of cholagogue and choleretic medication in biliary disorders].
    DEBRAY C; HARDOUIN JP
    Rev Prat; 1962 Feb; 12():596-9. PubMed ID: 13884680
    [No Abstract]   [Full Text] [Related]  

  • 2. [On a combination of a synthetic choleretic and a "mixed" spasmolytic with vitamins B-I and PP, in the therapy of some hepatobiliary diseases. Clinical study].
    ABBONA C; GATTO PL
    Minerva Med; 1962 May; 53():1486-91. PubMed ID: 13858818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-experimental study on a new substance with choleretic action (1-phenyl-1-hydroxy-n-pentane) associated with a spasmolytic having double atropine- and papaverine-like action in patients with hepatobiliary diseases].
    VANCINI B
    Minerva Med; 1962 May; 53():1478-86. PubMed ID: 13924674
    [No Abstract]   [Full Text] [Related]  

  • 4. [SIGNIFICANCE AND USES OF CHOLAGOGUE THERAPY].
    GROSSI F
    Clin Ter; 1964 Apr; 29():140-60. PubMed ID: 14163564
    [No Abstract]   [Full Text] [Related]  

  • 5. [TREATMENT OF SOME HEPATO-BILIARY DISEASES WITH AN ASSOCIATION OF DRUGS WITH CHOLERETIC, CHOLAGOGUE AND HEPATOPROTECTIVE ACTION].
    ABBONA C; GATTO PL; RAFFETTO A; BEZANTE GC
    Arch Maragliano Patol Clin; 1964 Oct; 20():439-56. PubMed ID: 14235315
    [No Abstract]   [Full Text] [Related]  

  • 6. [Apropos of the therapy of hepatovesical disorders with special reference to the cholagogic and choleretic effects of chlorobicarbonated thermal springs].
    LA BARRE J
    J Belge Med Phys Rhumatol; 1959; 14():140-50. PubMed ID: 14413104
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biliary dynamics and cholagogue therapy in relation to the behavior of the colon].
    Messini M; Grossi F
    Arch Ital Sci Farmacol; 1965; 15(1):77-9. PubMed ID: 5871025
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholagogue and choleretic action of mineral waters].
    Messina B
    Clin Ter; 1974; 70(2):110-2. PubMed ID: 4408868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phytotherapy of liver and biliary diseases].
    SVOBODA DH
    Medizinische; 1959 Sep; 38():1772-4. PubMed ID: 13835972
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with felicur, a choleretic with a new pharmacological base].
    DOPKE G
    Munch Med Wochenschr; 1955 Dec; 97(52):1743-4. PubMed ID: 13288530
    [No Abstract]   [Full Text] [Related]  

  • 11. [Choleretic action of Vichy waters studied by stercobilin stercobilin determination].
    BONNET GF; NEPVEUX P; NEPVEUX F
    Sem Hop; 1954 Nov; 30(75):4164-9. PubMed ID: 13225816
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cholagogic agents].
    Pasichnyk IKh
    Farm Zh; 1978; (2):39-43. PubMed ID: 658339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications and contraindications of choleretic therapy].
    Grossi F
    Clin Ter; 1974; 70(2):108-9. PubMed ID: 4409826
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE EFFECTIVENESS OF BERBERIN, A CHOLAGOGUE DRUG, IN CHRONIC INFLAMMATORY DISEASES OF THE BILIARY SYSTEM].
    LEISHCHINSKII LA; VARFOLOMEEVA TB; ORESHKOV TM; PETUKHOVA NI
    Sov Med; 1964 Jul; 28():120-2. PubMed ID: 14246962
    [No Abstract]   [Full Text] [Related]  

  • 15. [The "cholereticmorphine" test. Its value in diseases of the biliary tract and in migraines].
    DEBRAY C; HARDOUIN JP; FABLET J
    Gastroenterologia; 1962; 97():137-48. PubMed ID: 13884678
    [No Abstract]   [Full Text] [Related]  

  • 16. The cholagogue and choleretic effects of certain laxatives when introduced by duodenal tube.
    TWISS JR; ASHE BI; JOHNSON HJ
    Am J Dig Dis; 1953 Jul; 20(7):194-200. PubMed ID: 13057844
    [No Abstract]   [Full Text] [Related]  

  • 17. [COMBINATION OF A CHOLERETIC AND A SPASMOLYTIC IN BILIARY PATHOLOGY].
    FIERLAFIJN E
    Scalpel (Brux); 1965 Mar; 118():245-9. PubMed ID: 14325148
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with florantirone in patients with liver and gallbladder diseases].
    ETIENNE L
    Sem Med; 1960 Jan; 116():48-9. PubMed ID: 13820905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological and clinical aspects of the use of a new choleretic, 1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride].
    Grossi F; Spada S
    Clin Ter; 1969 Aug; 50(3):203-32. PubMed ID: 5387397
    [No Abstract]   [Full Text] [Related]  

  • 20. [The action of the cholecystokinetic drugs in alithiasic gallbladder stasis. Radiological signs in the strawberry gallbladder].
    URRUTIA JM; SEGURA JC
    Bol Trab Soc Cir B Aires; 1960 Nov; 44():803-13. PubMed ID: 13779336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.